NeoGenomics (United States)
In research, NeoGenomics (United States) stands highest in Health Sciences (#15,750 of 16,688 worldwide) and Medicine (#13,850 of 14,558 worldwide), over all time. Relative to its size it is most specialised in Biochemistry, Genetics and Molecular Biology (Biochemistry, Genetics and Molecular Biology is 7.0× its share of world research).
- World rank, 2022-now
- #21,961 of 22,385 · #34,145 all time
- Rank in United States
- #3,260 of 3,332
- Research works
- 271 ▲ 5% vs 2018-21
- Citations
- 3k 11.0 per fractional work
- Top-10% rate
- 6.7% all institutions 10.0%
- vs its own fields
- 0.88× 1.00× is exactly expected
- Open access
- 31% world 40%
- International
- 20% world 18%
What is NeoGenomics (United States) known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| Health SciencesDomain | #15,750 of 16,688 | 9.7% | 136 | |
| MedicineField | #13,850 of 14,558 | 9.7% | 134 |
Each strip is that field's whole ranked pool, with the notch where NeoGenomics (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).
Which fields of science does NeoGenomics (United States) work in?
In 2022-now, 43% of research at NeoGenomics (United States) is in Health Sciences, 42% in Life Sciences. Its largest fields are Medicine (43%), Biochemistry, Genetics and Molecular Biology (37%), Computer Science (6%). It does 2.8× the world's share of Life Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 22 fields, with their numbers
- Health Sciences4843.4%
- Medicine4742.8%
- Health Professions00.3%
- Dentistry00.2%
- Nursing00.2%
- Life Sciences4742.3%
- Physical Sciences1312.0%
- Computer Science76.3%
- Engineering43.6%
- Chemistry10.9%
- Environmental Science10.6%
- Physics and Astronomy00.2%
- Energy00.2%
- Earth and Planetary Sciences00.1%
- Mathematics00.1%
- Social Sciences32.3%
What does NeoGenomics (United States) specialise in?
Where its research is concentrated relative to its size: Biochemistry, Genetics and Molecular Biology takes 7.0× the share of its output that it takes of world research.
- Biochemistry, Genetics and Molecular BiologyField · 41.0 works7.0×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 7.0×. Every wedge is a field page.
All 22 fields, with their numbers
- Biochemistry, Genetics and Molecular Biology6.96×41 works
- Immunology and Microbiology3.17×4 works
- Medicine2.22×47 works
- Neuroscience0.97×2 works
- Computer Science0.81×7 works
- Chemistry0.58×1 works
- Dentistry0.44×0 works
- Nursing0.31×0 works
- Decision Sciences0.26×0 works
- Engineering0.24×4 works
- Energy0.16×0 works
- Economics, Econometrics and Finance0.16×0 works
- Environmental Science0.11×1 works
- Health Professions0.11×0 works
- Psychology0.10×0 works
- Social Sciences0.10×2 works
- Physics and Astronomy0.09×0 works
- Agricultural and Biological Sciences0.08×0 works
- Mathematics0.08×0 works
- Earth and Planetary Sciences0.06×0 works
- Arts and Humanities0.02×0 works
- Business, Management and Accounting0.02×0 works
- Biochemistry, Genetics and Molecular Biology 7.0×
- Immunology and Microbiology 3.2×
- Medicine 2.2×
- Neuroscience 1.0×
- Computer Science 0.8×
- Chemistry 0.6×
- Dentistry 0.4×
- Nursing 0.3×
- Decision Sciences 0.3×
- Engineering 0.2×
- Energy 0.2×
- Economics, Econometrics and Finance 0.2×
- Environmental Science 0.1×
- Health Professions 0.1×
- Psychology 0.1×
- Social Sciences 0.1×
- Physics and Astronomy 0.1×
- Agricultural and Biological Sciences 0.1×
- Mathematics 0.1×
- Earth and Planetary Sciences 0.1×
- Arts and Humanities 0.0×
- Business, Management and Accounting 0.0×
Who are the top researchers at NeoGenomics (United States)?
Ranked on the quality score, Christodoulos Pipinikas, Vincent Anthony Funari and Anna Juncker‐Jensen lead among researchers whose main affiliation is NeoGenomics (United States).
- 1
Christodoulos Pipinikas
United States · #345,583 worldwide 1.5k citations · 74 works
- 2
Vincent Anthony Funari
United States · #357,149 worldwide 6.2k citations · 114 works
- 3
Anna Juncker‐Jensen
United States · #1,006,880 worldwide 1.1k citations · 68 works
- 4
Sucha Sudarsanam
United States · #1,481,164 worldwide 11k citations · 40 works
- 5
Samuel Koo
United States · #1,551,118 worldwide 1.1k citations · 27 works
- 6
Harry Nunns
United States · #1,608,398 worldwide 241 citations · 68 works
- 7
Josette William
United States · #1,961,638 worldwide 1.1k citations · 30 works
- 8
Fernando J. López-Díaz
United States · #2,059,667 worldwide 691 citations · 48 works
- 9
Segun C. Jung
United States · #2,297,311 worldwide 1.1k citations · 52 works
- 10
Madhuri Paul
United States · #2,853,372 worldwide 66 citations · 90 works
Which keywords describe research at NeoGenomics (United States)?
By fractional works in 2022-now, weighted toward what it does more of than the world: Targeted Therapy, Cell-Free DNA, Genomic Instability, Cancer Genomics, Mutational Signatures, Immunotherapy, Gene Expression and Prognostic Factors.
- Transcriptional Regulation
- Genomic Profiling
- High-Throughput Analysis
- Data Analysis
- AML
- Metastasis
- Texture Analysis
- Rituximab
- Immune Checkpoint Blockade
- Arginine Deprivation
- Tumor Regression
- Breast Cancer
- Nanoparticles
- Gene Therapy
- Chemotherapy
- Machine Learning
- Prognostic Factors
- Immunotherapy
- Cancer Genomics
- Cell-Free DNA
- Targeted Therapy
- Genomic Instability
- Mutational Signatures
- Gene Expression
- Tumor Microenvironment
- Cancer
- Tumor Targeting
- Precision Medicine
- Clinical Trials
- Biomarkers
- Quantitative Analysis
- Bacterial Therapy
- PD-1 and PD-L1
- Feature Extraction
- Hematopoietic Stem Cells
- Radiomics
- Acute Myeloid Leukemia
- PET Imaging
- Protein Microarrays
- Molecular Profiling
Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Targeted Therapy13▲ 51×4 topics
- Cell-Free DNA10▲ 92×2 topics
- Genomic Instability10▲ 79×2 topics
- Cancer Genomics10▲ 124×1 topic
- Mutational Signatures10▲ 124×1 topic
- Immunotherapy8▲ 9.4×11 topics
- Gene Expression7▲ 10×9 topics
- Prognostic Factors7▲ 15×7 topics
- Tumor Microenvironment7▲ 14×6 topics
- Machine Learning7▲ 1.87×8 topics
- Cancer7▲ 4.6×18 topics
- Chemotherapy6▲ 7.7×11 topics
- Tumor Targeting5▲ 24×2 topics
- Gene Therapy5▲ 22×3 topics
- Precision Medicine4▲ 8.2×4 topics
- Nanoparticles4▲ 3.1×5 topics
- Clinical Trials4▲ 5.3×7 topics
- Breast Cancer4▲ 14×9 topics
- Biomarkers4▲ 4.8×9 topics
- Tumor Regression4▲ 30×2 topics
- Quantitative Analysis3▲ 15×2 topics
- Arginine Deprivation3▲ 77×1 topic
- Bacterial Therapy3▲ 77×1 topic
- Immune Checkpoint Blockade3▲ 26×1 topic
- PD-1 and PD-L13▲ 26×1 topic
- Rituximab3▲ 20×2 topics
- Feature Extraction3▲ 6.1×2 topics
- Texture Analysis3▲ 13×2 topics
- Hematopoietic Stem Cells3▲ 30×3 topics
- Metastasis3▲ 7.4×5 topics
- Radiomics3▲ 21×1 topic
- AML3▲ 49×1 topic
- Acute Myeloid Leukemia3▲ 49×1 topic
- Data Analysis2▲ 8.5×3 topics
- PET Imaging2▲ 14×3 topics
- High-Throughput Analysis2▲ 58×1 topic
- Protein Microarrays2▲ 118×1 topic
- Genomic Profiling2▲ 19×2 topics
- Molecular Profiling2▲ 21×3 topics
- Transcriptional Regulation2▲ 12×3 topics
Which research topics does NeoGenomics (United States) publish most on?
By volume in 2022-now: Cancer Genomics and Diagnostics, Cancer Research and Treatments, Cancer Immunotherapy and Biomarkers and Radiomics and Machine Learning in Medical Imaging.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Genomics and Diagnostics Cancer Research 10 works
- 2 Cancer Research and Treatments Biotechnology 3 works
- 3 Cancer Immunotherapy and Biomarkers Oncology 3 works
- 4 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 3 works
- 5 Acute Myeloid Leukemia Research Hematology 3 works
- 6 Advanced Biosensing Techniques and Applications Molecular Biology 2 works
- 7 Protein Degradation and Inhibitors Molecular Biology 2 works
- 8 Cancer, Hypoxia, and Metabolism Cancer Research 2 works
- 9 Single-cell and spatial transcriptomics Molecular Biology 2 works
- 10 Myeloproliferative Neoplasms: Diagnosis and Treatment Genetics 2 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has NeoGenomics (United States)'s research output changed?
Output in 2022-2025 was 5% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is NeoGenomics (United States) as a percentage of every work published that year, 0.00050% in 2024.
Fractional works of NeoGenomics (United States) over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year, against all institutions in the same year.
Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 17.3% in 2021.
Other research institutions in Aliso Viejo
- Soka University of America
- American Association of Critical-Care Nurses
- Ambry Genetics (United States)
- Microsemi (United States)
- Avanir Pharmaceuticals (United States)
- NVision Eye Centers (United States)
- RxSight (United States)
- Inceptus (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about NeoGenomics (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.
